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Abstract
BACKGROUND: The global prevalence of type 2 diabetes mellitus (DM), a chronic metabolic disorder, has been 
steadily increasing. Increasing blood sugar levels (BSL) are reliably measured by glycated hemoglobin (HbA1c). 
AIM: The aim of this research is to observe the relation between lipid profile with glycemic control at uncontrolled and 
controlled type 2 DM, early detection of abnormalities in the lipid profile can minimize cardiovascular complication 
risk in patients with type 2 DM.
METHODS: Collecting medical data record, for example, blood pressure, height and body mass index, duration 
of disease, family history, and medicine treatment. Laboratory examination such as BSL, HbA1c levels, and lipid 
profile such as cholesterol, low-density lipoprotein, high-density lipoprotein, and triglycerides (TGs) was evaluated. 
The study was conducted by implementing cross-sectional methods, among 112 patients with type 2 DM who were 
admitted from various primary health-care centers in Medan city and the surrounding areas in North Sumatera. The 
sample criteria are type 2 DM’ patients and both genders. The exclusion criteria of the samples are those with type 
1 DM and critical disease.
RESULTS: There is a difference between the average lipid profile level (high-density lipoprotein and TG) in controlled 
and uncontrolled type 2 DM. Furthermore, there is also a difference between the average HbA1c value in controlled 
type 2 DM and uncontrolled type 2 DM (p<0.005).
CONCLUSION: This study showed a difference in lipid profile (high-density lipoprotein and TG) and HbA1c between 
uncontrolled and controlled type 2 DM. Therefore, type 2 DM patients were recommended to undergo periodical 
glycemic and lipid profile examination control to prevent cardiovascular disease complication.
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Introduction
Diabetes mellitus (DM) is a common 
metabolic disorder characterized by absolute or 
relative deficiencies in insulin secretion and/or insulin 
action associated with chronic hyperglycemia [1]. The 
prevalence is rapidly increasing in both developing and 
developed countries [2], [3]. Based on the International 
Diabetes Federation, in 2019, the prevalence of adult 
population aged 20–79 years who suffer from DM 
reaches 463 million and is expected to increase to 700 
million by 2045. It is stated that 1 in 5 people aged 
over 65 years suffer from DM and causes 4.2 million 
deaths globally [4]. Type 2 DM is often associated with 
an increased risk marker for cardiovascular disease. 
Individuals with Type 2 DM carry an absolute risk of 
major coronary events similar to that of non-diabetic 
individual with established coronary heart disease 
(CHD) because it is often associated with lipoprotein 
metabolism abnormalities that are responsible 
for microvascular or macrovascular complication 
risk [4], [5]. Furthermore, CHD has a higher mortality 
risk in people with DM than those who do not suffer 
from DM [6], [7].
In type 2 DM, lipid abnormalities are 
common. Typical findings include elevation of total 
and very low-density lipoprotein (LDL) cholesterol, 
triglyceride (TG) concentration, exaggerated 
postprandial lipemia, lower high-density lipoprotein 
(HDL) cholesterol, and a predominance of small, 
dense LDL-cholesterol (LDL-C) particles [8]. Insulin 
resistance often occurs in this process [9]. Increasing 
TGs have been associated with increased risk of 
CHD both in non-diabetic and diabetic subjects [10]. 
Dyslipidemia is related to lifestyle factors, such as 
diet and daily activities, and related to metabolic 
syndrome as well [11]. The pro-atherogenic properties 
of small LDL particles might be related to their ability 
to penetrate the arterial wall and thereby making 
them more susceptible to oxidation, indirectly linked 
with coronary artery disease [12].
This study aims to evaluate the relation of lipid 
profile with glycemic control in type 2 DM who attended 
health-care centers in and around Medan city.
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Materials and Methods
In this study, there were 118 samples with 
type 2 DM, the samples were recruited from health-
care center in Medan, Binjai, and Stabat city, North 
Sumatera, Indonesia. The recruitment was conducted 
from May to July 2020. Patients with diabetics who take 
oral hypoglycemic agents, follow specific diet regimen 
or incorporate insulin for glycemic control were included 
in the study. Permission from the Institutional Review 
Committee was obtained. Patients were informed with 
the detail of the study. Written consent was obtained 
from the patients before they participated in the study. 
Due to COVID-19, personal protective equipment was 
used to prevent COVID-19 transmission. In addition, 
all the samples wore mask whenever they were in the 
clinic.
We measured height and weight with the 
subjects standing in light clutches. Body mass index 
(BMI) was calculated by dividing the subject’s weight in 
kilogram to the square of the subject’s height in meters 
(kg/m2). Average blood pressure was calculated by 
measuring the subjects twice after the subject had been 
seated for at least 5 min. The subject fasted overnight 
to provide a blood specimen. Blood samples were 
collected (using syringe) and transferred to Paramitha 
clinical laboratory immediately to be examined for blood 
sugar, glycosylated hemoglobin, and lipid profile. The 
examination of blood sugar levels (BSL) was conducted 
with hexokinase methods. Whereas, the examination 
of glycosylated hemoglobin was conducted with 
HPLC methods and the examination of lipid profile 
was conducted with direct CHOD PAP and GPO PAP. 
Glycosylated hemoglobin test was carried out for the 
patients because this examination is a gold standard for 
type 2 DM patients.
Statistical analysis
SPSS version 24.0 (SPSS Inc., Chicago, 
Illinois) statistical software was used for statistical 
analysis. All the variables in this sample of the study 
were tested by Shapiro–Wilk, the normal distribution 
variables (p > 0.005) were tested by parametric 
correlation test, but the abnormal distribution variables 
(p < 0.005) were tested by non-parametric test.
Results
We evaluated clinical and laboratory findings 
in 118 patients with Type 2 DM. Of the total number of 
subjects, 28.8% (34) were male, and 71.2% (84) of the 
subjects were female. There were 51 samples (43.2%) 
with controlled type 2 DM and 67 samples (56.8 %) with 
uncontrolled type 2 DM. The lowest BMI of the samples 
was 17.63 kg/m2 and the highest BMI was 46.44 kg/m2, 
with average BMI of 26.17 kg/m2 and SD 5.47 kg/m2. 
Table 1: Descriptive statistics
Variables n Minimum Maximum Mean SD
HbA1c 118 4.70 14.70 8.87 2.58
BMI (kg/m2) 118 17.63 46.44 26.17 5.47
Abdominal circumference (cm) 118 64 121 90.80 10.93
Systole (mmHg) 118 98 216 145.79 22.76
Diastole (mmHg) 118 60 113 86.36 10.29
BSL (mg/dL) 118 73 610 254.55 135.01
Cholesterol (mg/dL) 118 111 342 216.53 44.65
HDL (mg/dL) 118 24 77 47.25 11.52
LDL (mg/dL) 118 50 259 127.47 37.42
TG (mg/dL) 118 49 1157 233.63 144.97
HbA1c: Glycated hemoglobin, BMI: Body mass index, BSL: Blood sugar level, HDL: High-density 
lipoprotein, LDL: Low-density lipoprotein, TG: Triglyceride.
The lowest abdominal circumference was 64 cm, the 
highest was 121 cm with 90.80 cm in average and SD 
of 10.93 cm. The lowest glycated hemoglobin (HbA1c) 
value was 4.7% and the highest value was 14.7% with an 
average of 8.87% and SD value of 2.58%. The minimum 
age of the samples was 35 years old; the maximum age 
was 79 years old with 56.96 years in average and SD of 
9.43 years. The lowest measurement of blood pressure 
level was 98 mmHg (systole) and 60 mmHg (diastole); the 
highest measurement was 216 mmHg and 113 mmHg with 
average value of 145.79 mmHg and 86.36 mmHg and SD 
of 22.76 and 10.29 mmHg. The lowest BSL of the sample 
was 73 mg/dL, the highest of BSL levels was 610 mg/dL, 
and the average BSL was 254.55 mg/dL and SD 135.01 
mg/dL. The lowest cholesterol value of the sample was 
111 mg/dL and the highest value was 342 mg/dL with 
an average of 216.53 mg/dL and SD of 44.65 mg/dL. 
Table 2: Data characteristic of the samples
Variables Gender n Mean
Age (years) Male 34 59.91 ± 9.35
Female 84 55.76 ± 9.24
Abdominal circumference (cm) Male 34 92.35 ± 12.13
Female 84 90.17 ± 10.42
BMI (kg/m2) Male 34 25.75 ± 5.06
Female 84 26.34 ± 5.65
BMI: Body mass index.
The minimum HDL value was 24 mg/dL, the maximum 
value was 77 mg/dL, the mean value was 47.25 mg/dL and 
SD of 11.52 mg/dL. The minimum LDL value was 50 mg/
dL, the maximum value was 259 mg/dL with an average 
of 127.47 mg/dL and SD of 37.42 mg/dL. The minimum 
TG value was 49 mg/dL and the maximum TG value was 
1157 mg/dL with the mean value of 233.63 mg/dL and SD 
of 144.97 mg/dL (Tables 1-6).
Table 3: Biomarker metabolic concentration of the samples
Variables Gender n Mean SD
Blood sugar levels Male 34 245.15 119.98
Female 84 258.36 141.14
Cholesterol Male 34 209.76 41.80
Female 84 219.27 45.71
HDL Male 34 43.15 9.41
Female 84 48.90 11.93
LDL Male 34 130.47 32.33
Female 84 126.25 39.41
TG Male 34 199.62 87.88
Female 84 247.39 160.90
HbA1c Male 34 9.0 2.70
Female 84 8.82 2.56
HDL: High-density lipoprotein, LDL: Low-density lipoprotein, TG: Triglyceride, HbA1c: Glycated hemoglobin.
In the test studies, there was a difference in the 
average lipid profile level (HDL and TG) in controlled 
and uncontrolled Type 2 DM and also a difference in 
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the average HbA1 C value in controlled type 2 DM and 
uncontrolled type 2 DM (p < 0.005).
Table 4: Family history of the samples
Family history Frequency Percentage
No family history 82 69.5
Family history 36 30.5
Total 118 100.0
Discussion
There were more females (71.2%) than 
males (28.8%) with Type 2 DM in this study. The 
high proportion of female in this study may be due 
to the nature of patients who were getting admitted 
to the primary health-care center. It happened due 
to the reason that more females seek for medical 
attention compared to males, because most of them 
are housewives and they have more spare time. 
Table 5: Data of samples based on controlled and 
uncontrolled
Variables Frequency Percentage
Controlled Type 2 DM 51 43.2
Uncontrolled Type 2 DM 67 56.8
Total 118 100.0
DM: Diabetes mellitus.
Various studies have clearly established that Type 
2 DM’s complications are mainly due to chronic 
hyperglycemia that is harmful for health through 
several mechanisms: Dyslipidemia, platelet activation, 
and altered endothelial metabolism [13]. Lipid profile 
and DM were the important predictors for metabolic 
disturbance including dyslipidemia, hypertension, and 
cardiovascular disease [14]. Lipids play a key role in 
the pathogenesis of DM. Dyslipidemia as a metabolic 
abnormality is frequently associated with DM. 
Table 6: T-test of the results
t-test p value 
HbA1c <0.005
Cholesterol >0.005
HDL <0.005
LDL >0.005
TG <0.005
CRI <0.005
TD systole >0.005
TD diastole >0.005
BMI >0.005
HbA1c: Glycated hemoglobin, HDL: High-density lipoprotein, LDL: Low-density lipoprotein, TG: 
Triglyceride, BMI: Body mass index.
Abnormalities in lipid metabolism have been reported 
in patients who suffer from DM with the risk of 
cardiovascular arteriosclerosis [15]. In this study, it was 
found that the average serum levels of total cholesterol 
and TGs were significantly higher than the normal value, 
which are known as risk factors for cardiovascular 
diseases among patients. Patients with type 2 DM were 
twice as likely to develop cardiovascular disease than 
those without DM regardless of age, smoking status, 
BMI, and systolic blood pressure [16]. Furthermore, the 
mortality risk from vascular causes is more than doubled 
in patients with DM [17]. In this study, a difference in 
the average levels of HDL and TGs in the controlled 
and the uncontrolled type 2 DM was found. Improving 
glycemic control can substantially reduce the risk of 
cardiovascular events in diabetics [18]. Rina et al. stated 
that there was a correlation between HbA1c levels and 
the total cholesterol serum in patients with uncontrolled 
Type 2 DM [19]. A study by Samdani et al. showed that 
there was a significantly positive correlation between 
HbA1c with lipid profile, especially LDL-C [20]. Other 
study conducted by Erciyas et al., also reported positive 
correlation of HbA1c level with TC and TG in diabetic 
patients [21]. Goldberg reported that dyslipidemia in 
type 2 DM might be caused by dysfunctional insulin 
production which affects the liver apolipoprotein 
production and the apolipoprotein that regulates the 
enzymatic activity of lipoprotein lipase and cholesterol 
ester transport protein [22]. Another study by Ozder 
reported that there were a significantly higher average 
serum levels of TC, TG, and LDL and significantly 
lower average serum levels of HDL in patients with 
diabetes [23]. Diet control, exercise, and medicine have 
been the main treatments for patients with diabetes. A 
research by Widjaja et al. which incorporates traditional 
medicine like basil leaves extracts to decrease blood 
glucose showed that it could significantly lower blood 
glucose between the diabetic control group and the 
group treated [24].
In this study, the youngest participant was 
35 years old and the oldest was 79 years old. There 
was a significant relation between the subjects’ age 
with familial history. There was a significant relation 
between the occurrence of Type 2 DM, family history 
(from fraternal, maternal, or both), lifestyle factors, 
and genetics in the youngest participant [25], [26]. 
Several lifestyle factors are known to be important to 
the development of type 2 DM. These are physical 
inactivity, sedentary lifestyle, smoking status, and 
generous consumption of alcohol [27]. A study by Sari 
et al. reported that postprandial glucose levels were 
different in smoking compared to non-smoking diabetic 
patients. Smoking may contribute to the development 
of insulin resistance as there were higher postprandial 
glucose levels in smoking diabetic patients compared 
to the non-smoking diabetic patients [28]. Obesity has 
been found to contribute to approximately 55% of cases 
of type 2 DM [29]. Although individual predisposition 
to T2DM has a strong genetic basis, evidence from 
epidemiological studies suggests that many cases of 
T2DM can be prevented with lifestyle modifications [30].
Modification of lifestyle, including weight loss, 
increasing physical activity, and adopting a healthy 
diet, remains one of the first-line strategies for the 
management of T2DM to decrease lipid profile level, 
such as TGs and LDL and to increase HDL level [31]. 
A study by Rina et al reported that self-efficacy related 
to the management of diabetes in terms of self-
management has an impact on glycemic control and 
will certainly able to reduce complications and ultimately 
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improve the life quality of patients [32]. Furthermore, 
self-efficacy behavior has a positive and significant 
effect on quality of life, metabolic level, and lipid control 
in type 2 DM patients [33], [34].
Conclusion
Uncontrolled type 2 DM was associated with 
increasing lipid profile that was known as a risk factor 
to cardiovascular complication. Better glycemic control 
of HbA1c would also reflect on a better lipidemic state. 
HbA1c can be used as an indicator of glycemic control 
as well as a predictor of dyslipidemia in Type 2 DM.
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